BamSEC and AlphaSense Join Forces
Learn More

VYNE Therapeutics Inc.

NASDAQ: VYNE    
Share price (1/8/25): $3.92    
Market cap (1/8/25): $57.8 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.1
from 8-K 3 pages VYNE Therapeutics Inc. First Amendment to 2023 Equity Incentive Plan
12/34/56
EX-10.17
from 10-K 2 pages VYNE Therapeutics Inc. Non-Employee Director Compensation Policy
12/34/56
EX-10.3
from 10-K 37 pages VYNE Therapeutics Inc. $50,000,000 Sales Agreement
12/34/56
EX-10.4
from 8-K 9 pages VYNE Therapeutics Inc. Restricted Share Unit Grant Notice
12/34/56
EX-10.3
from 8-K 12 pages VYNE Therapeutics Inc. Share Option Grant Notice
12/34/56
EX-10.2
from 8-K 12 pages VYNE Therapeutics Inc. Share Option Grant Notice
12/34/56
EX-10.1
from 8-K 22 pages VYNE Therapeutics Inc. 2023 Equity Incentive Plan
12/34/56
EX-10.2
from 8-K 24 pages Registration Rights Agreement
12/34/56
EX-10.1
from 8-K 32 pages Securities Purchase Agreement
12/34/56
EX-10.1
from 10-Q 54 pages Certain Identified Information Has Been Omitted From This Document Because It Is Both Not Material and Would Be Competitively Harmful if Publicly Disclosed, and Has Been Marked With “[***]” to Indicate Where Omissions Have Been Made License Agreement
12/34/56
EX-10.1
from 10-Q 3 pages Certain Identified Information Has Been Omitted From This Document Because It Is Both Not Material and Would Be Competitively Harmful if Publicly Disclosed, and Has Been Marked With “[***]” to Indicate Where Omissions Have Been Made
12/34/56
EX-10.2
from 10-Q 18 pages Registration Rights Agreement
12/34/56
EX-10.1
from 10-Q 23 pages Securities Purchase Agreement
12/34/56
EX-10.1
from 10-Q 5 pages Material contract
12/34/56
EX-10.13
from 10-K 16 pages Material contract
12/34/56
EX-10.12
from 10-K 18 pages Material contract
12/34/56
EX-10.2
from 8-K 14 pages Registration Rights Agreement
12/34/56
EX-10.1
from 8-K 38 pages Purchase Agreement
12/34/56
EX-10.2
from 10-Q 22 pages Evaluation and Option Agreement
12/34/56
EX-10.1
from 10-Q 53 pages Certain Identified Information Has Been Omitted From This Document Because It Is Both Not Material and Would Be Competitively Harmful if Publicly Disclosed, and Has Been Marked With “[***]” to Indicate Where Omissions Have Been Made. License Agreement
12/34/56